PEDIATRIC BLOOD & CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2024-01-25 1de6eac2m62(暂无匿称) 来自河北省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：儿童肿瘤;儿科
经验分享：怎么网站没有办法注册呢？投不了稿

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2023-04-09 ms5000000259255905 来自北京

2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2019-04-06 syweiang

审稿速度:1.0
经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用

162 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2018-09-11 波0

31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表:
immediately reject and recommend to resubmit as a brief report format.

波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format.

228 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

这些都是外文期刊吗

159 0

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2019-06-05 波0

hepatoblastomadyt14 2019-05-04 00:00:00 发表:
请问你是什么方向啊

dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊

175 0

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2019-05-04 dyt14

请问你是什么方向啊波0 2018-09-11 发表::
31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表:
31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept

波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept

165 0

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2018-06-21 波0

immediately reject and recommend to resubmit as a brief report format.

248 0

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2017-07-18 13801938855

跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜

351 0

[GetPortalCommentsPageByObjectIdResponse(id=2183851, encodeId=8cad2183851aa, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：儿童肿瘤;儿科 经验分享：怎么网站没有办法注册呢？投不了稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=037e1696454, createdName=1de6eac2m62(暂无匿称), createdTime=Thu Jan 25 11:24:03 CST 2024, time=2024-01-25, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124531, encodeId=9abe2124531dd, content=2.17提交，3.14一大修一一小修，3.24修回，现在还在等二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Sun Apr 09 02:26:00 CST 2023, time=2023-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569206, encodeId=94025692062a, content=审稿速度:1.0 经验分享：To the editor1天审回，2天返修，3天二次返修，第四天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sat Apr 06 00:00:00 CST 2019, time=2019-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560939, encodeId=3f5056093918, content=31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., beContent=波0 2018-06-21 00:08:00 发表: immediately reject and recommend to resubmit as a brief report format., objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Sep 11 00:00:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578525, encodeId=51925e8525e1, content=这些都是外文期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571928, encodeId=b9a05e1928fd, content=hepatoblastomadyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, beContent=dyt14 2019-05-04 00:00:00 发表: 请问你是什么方向啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Wed Jun 05 00:00:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570425, encodeId=2b7e5e042532, content=请问你是什么方向啊波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept波0 2018-09-11 00:00:00 发表: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, beContent=波0 2018-09-11 发表:: 31 July Submit 20 August Major revision 25 August Resubmit 10 September Accept, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTITkCOtynfiaF5Z6apDXYOOq5yk2r46ibrWPM9bic6kcCX87bx8uHWgQ4OHb2FQGicCnqMoib82KxJ1WuA/132, createdBy=289b2477385, createdName=dyt14, createdTime=Sat May 04 00:00:00 CST 2019, time=2019-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558147, encodeId=2e6255814e12, content=immediately reject and recommend to resubmit as a brief report format., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Thu Jun 21 00:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539923, encodeId=2a0e539923a8, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514202, encodeId=960251420245, content=审稿一个月，编辑非常认真，对论文改进很有帮助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2TdCQXNqUrxSI1q1tQujVSqnfvvlLrLuqH5POn7gCqftaNjQaz3fmOJMM36zyfyicZnY0jOdEh7w/132, createdBy=68791618265, createdName=sideprince, createdTime=Tue Aug 04 15:55:00 CST 2015, time=2015-08-04, status=1, ipAttribution=)]

2015-08-04 sideprince

审稿一个月，编辑非常认真，对论文改进很有帮助

298 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务